Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 23 (16), 2854-2869

Importance of Antimicrobial Susceptibility Testing for the Management of Eradication in Helicobacter pylori Infection


Importance of Antimicrobial Susceptibility Testing for the Management of Eradication in Helicobacter pylori Infection

Nazlı Arslan et al. World J Gastroenterol.


The management of Helicobacter pylori (H. pylori) infection treatment differs from the common treatment protocol for other infectious diseases. Because culture- or molecular-guided approaches face several practical issues, such as the invasive procedures required to obtain gastric biopsy specimens and the lack of availability of routine laboratory testing in some places, H. pylori treatment includes the administration of two or three empirically selected antibiotics combined with a proton pump inhibitor rather than evidence-based eradication treatment. The efficacy of empirical therapy is decreasing, mostly due to increasing multiple resistance. Multiresistance to levofloxacin, clarithromycin, and metronidazole, which are commonly used in empirical treatments, appears to have increased in many countries. Mutations play a primary role in the antimicrobial resistance of H. pylori, but many different mechanisms can be involved in the development of antibiotic resistance. Determining and understanding these possible mechanisms might allow the development of new methods for the detection of H. pylori and the determination of antimicrobial resistance. A treatment based on the detection of antimicrobial resistance is usually more effective than empirical treatment. Nevertheless, such an approach before treatment is still not recommended in the Maastricht guidelines due to the difficulty associated with the routine application of available culture- or molecular-based susceptibility tests, which are usually administered in cases of treatment failure. The management of first and rescue treatments requires further research due to the steadily increase in antimicrobial resistance.

Keywords: Antimicrobial resistance; Antimicrobial susceptibility testing; Helicobacter pylori; Susceptibility-guided therapy; Treatment management.

Conflict of interest statement

Conflict-of-interest statement: Arslan N, Yılmaz Ö and Demiray-Gürbüz E declare no conflicts of interest related to this publication.

Comment in

Similar articles

See all similar articles

Cited by 10 PubMed Central articles

See all "Cited by" articles


    1. Hunt RH, Smaill FM, Fallone CA, Sherman PM, Veldhuyzen van Zanten SJ, Thomson AB. Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. Can J Gastroenterol. 2000;14:862–868. doi: 10.1155/2000/601256. - DOI - PubMed
    1. Larsen AL, Ragnhildstveit E, Moayeri B, Eliassen L, Melby KK. Resistance rates of metronidazole and other antibacterials in Helicobacter pylori from previously untreated patients in Norway. APMIS. 2013;121:353–358. doi: 10.1111/apm.12009. - DOI - PubMed
    1. McNulty CA, Lasseter G, Shaw I, Nichols T, D’Arcy S, Lawson AJ, Glocker E. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? Aliment Pharmacol Ther. 2012;35:1221–1230. doi: 10.1111/j.1365-2036.2012.05083.x. - DOI - PubMed
    1. Scaletsky IC, Aranda KR, Garcia GT, Gonçalves ME, Cardoso SR, Iriya K, Silva NP. Application of real-time PCR stool assay for Helicobacter pylori detection and clarithromycin susceptibility testing in Brazilian children. Helicobacter. 2011;16:311–315. doi: 10.1111/j.1523-5378.2011.00845.x. - DOI - PubMed
    1. Rajper S, Khan E, Ahmad Z, Alam SM, Akbar A, Hasan R. Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan. J Pak Med Assoc. 2012;62:1140–1144. - PubMed

MeSH terms